✅ FDAapproves the HIV-1 medication ibalizumab-uiyk for administration by intravenous push.
The Food and Drug Administration has approved the HIV-1 medication ibalizumab-uiyk for administration by intravenous push.by the FDA in 2018 for the treatment of adults with multidrug resistant HIV-1. It is used in combination with other antiretroviral drugs.
Prior to this approval, the drug was administered intravenously as a single 2000 mg loading dose, followed by an 800 mg maintenance dose every 2 weeks by a trained medical professional. The intravenous infusion is given over 15 to 30 minutes, according to the Trogarzo website. Now, the maintenance dose can be administered by IV push, a method where the undiluted medication is delivered intravenously by injection, in just 30 seconds.
"The evolution of Trogarzo administration from intravenous infusion to intravenous push means less preparation and treatment time in clinics for patients and their healthcare providers, possibly allowing for more clinics to administer this treatment," said Christian Marsolais, PhD, the chief medical officer of Theratechnologies, in anadministered via IV push had similar safety and pharmacokinetic profiles as the IV infusion method.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves treatment that ALS Ice Bucket Challenge helped fundIn 2014, people all over the world joined in on the ALS ice bucket challenge. It raised $115 million in donations, according to the ALS Association.
Weiterlesen »
Juul Prepares to Seek Financing for Potential Bankruptcy ProcessJuul Labs is expected as soon as this week to start discussions with lenders for financing that would carry the vaping company through a potential chapter 11 bankruptcy filing
Weiterlesen »
Advocates Urge FDA to Ease Access to Abortion Pill for Miscarriage ManagementMedical and advocacy groups are urging the FDA to add miscarriage management as a use case for mifepristone, a drug commonly used in medical abortions, and ease the restrictions around who can prescribe it. Via 19thnews
Weiterlesen »
Docs push to add miscarriage management to abortion pill labelObstetricians, gynecologists, other medical professionals, and abortion rights advocates petitioned the U.S. Food and Drug Administration (FDA) on Tuesday to urge Danco Laboratories to seek approval of mifepristone, a pill used in terminating early pregnancies at home, for miscarriage management. 'At this time, we are not planning to submit (an application) for miscarriage management, but may reconsider in the future,' a spokesperson said. Danco is currently working with the FDA on changes to where patients can get the drug.
Weiterlesen »
Remember the Ice Bucket Challenge? It Ended Up Funding a New ALS DrugThe 'Ice Bucket Challenge' to fund ALS research was so effective, it resulted in the development of a new drug that was just approved by the FDA.
Weiterlesen »